A Phase I, Single-Center, Open-Label, Single-Group Study to Evaluate Potential Pharmacodynamics of Drug-Drug Interaction Between SHR4640 and Febuxostat and Between SHR4640 and Colchicine in Patients With Gout
Latest Information Update: 12 Aug 2019
At a glance
- Drugs Colchicine (Primary) ; Febuxostat (Primary) ; Ruzinurad (Primary)
- Indications Gout
- Focus Pharmacokinetics
- Sponsors Jiangsu Hengrui Medicine Co.
- 06 Aug 2019 Status changed from recruiting to completed.
- 02 May 2017 New trial record